Targeted Oncology™, a print and digital resource that offers content and expert opinions on precision medicine in oncology, will launch the first Expert Perspective: Virtual Tumor Board on April 24
Masimo, announced recently the findings of an abstract presented at the 2018 Annual Meeting of the Network for the Advancement of Patient Blood Management, Haemostatis and Thrombosis (NATA), in which researchers investigated the utility of Masimo noninvasive and continuous hemoglobin (SpHb®) in supporting and enhancing red blood cell (RBC) transfusion best practices as part of post-operative patient blood management
Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the CE-IVD marking of Amplidiag CarbaR+MCR, a molecular test allowing detection of the main carbapenemase-producing organisms and colistin resistance markers in one single test. Antimicrobial resistance is currently one of the biggest threats to global health
Counsyl, a genetic screening company, will share insights into how OBGYNs can seamlessly integrate genetic screening into their practices at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, held from April 27 to April 30 in Austin, Texas
Innovive, the innovator and market leader in disposable rodent caging, is pleased to announce that it has issued a limited non-exclusive license to Allentown, Inc., a leader in the lab animal space
Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology.
PierianDx, the leading genomics technology companythat enables precision medicine, announced today a strategic partnership with RTI International to help solve the problem of translating complex genomic data into actionable clinical insight to advance precision medicine
PEP-Therapy, Institut Curie and Gustave Roussy join together to conduct the Clever-Peptide project. It aims at the development of an innovative anti-cancer peptide, firstly for the treatment of triple-negative breast cancer, and its companion biomarker, predictive of treatment efficacy
Genentech, a member of the Roche Group, announced recently that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to HEMLIBRA (emicizumab-kxwh) for people with hemophilia A without factor VIII inhibitors
South Korea’s Biostar Stem Cell Research Institute (CEO: Jeong-Chan Ra), jointly operated by Nature Cell and Rbio, recently announced that Trinity Clinic Fukuoka, a partner hospital in Japan, received approval for the application of regenerative medicine in Alzheimer’s disease and officially began stem cell treatment as of April 12
|
|
|
|
|
|
|
|
|